P152 - Combined analysis of molecular patterns and clinical factors for the prediction of immune checkpoint inhibitor therapy in advanced urothelial carcinoma
| Autor: | Szarvas, T., Varadi, M., Horvath, O., Soos, E., Fazekas, T., Csizmarik, A., Nemeth, B., Gyorffy, B., Kenessey, I., Reis, H., Koll, F., Olah, C., Hadaschik, B., Krafft, U., Mairinger, F., Wessolly, M., Hoffmann, M., Grunewald, C., Niegisch, G., Maraz, A., Kuthi, L., Furka, A., Nyirady, P. |
|---|---|
| Zdroj: | In European Urology March 2024 85 Supplement 1:S215-S216 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect